Pablo Cironi is the Director of Life Science Investment Funds at Caixa Capital Risc. He focuses on investment in therapeutics and medical devices. He currently serves on the Board of Directors at Medlumics, Aelix Therapeutics, Minoryx Therapeutics, iProteos, Proteodesign and Sanifit. Pablo has more than 12 years of experience in business development, technology transfer and in early stage investment.
Pablo graduated in Chemistry from the University of Buenos Aires, and holds a Ph.D. in Organic Chemistry from the University of Barcelona. From 2005 to 2009, he was a postdoctoral Fulbright Fellow at the Department of Systems Biology at Harvard University.